10-methyl spiro(4.5)dec-6-en-6-carboxylic acid has been researched along with Insulin Resistance in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, K; Colca, JR; Eichler, SJ; Ferguson, D; Finck, BN; Lutkewitte, AJ; McCommis, KS; Mukherjee, S; Niemi, NM; Patti, GJ; Shew, TM; Yiew, NKH | 1 |
1 trial(s) available for 10-methyl spiro(4.5)dec-6-en-6-carboxylic acid and Insulin Resistance
| Article | Year |
|---|---|
Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism.
Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Amino Acids, Branched-Chain; Animals; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin Resistance; Liver Neoplasms; Mice; Monocarboxylic Acid Transporters; Non-alcoholic Fatty Liver Disease; Rats; Rats, Zucker; TOR Serine-Threonine Kinases | 2023 |